Commentary on "Prevalence of Central Sensitization in Notalgia Paresthetica Patients and Its Association with Vertebral Degeneration: A Cross-sectional Study"

Cirakoglu D, Etgü F. Prevalence of central sensitization in notalgia paresthetica patients and its association with vertebral degeneration: a cross-sectional study. Acta Derm Venereol 2025; 105: adv44444. DOI: https://doi.org/10.2340/actadv.v105.44444

Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, et al. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain 2019; 160: 19–27. DOI: https://doi.org/10.1097/j.pain.0000000000001384

Gao YJ, Zhang L, Samad OA, Suter MR, Yasuhiko K, Xu ZZ, et al. JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. J Neurosci 2009; 29: 4096–4108. DOI: https://doi.org/10.1523/JNEUROSCI.3623-08.2009

Kosek E. The concept of nociplastic pain-where to from here? Pain 2024; 165: S50–S57. DOI: https://doi.org/10.1097/j.pain.0000000000003305

Available from: https://www.iasp-pain.org/resources/terminology

Neblett R, Cohen H, Choi Y, Hartzell MM, Williams M, Mayer TG, et al. The Central Sensitization Inventory (CSI): establishing clinically significant values for identifying central sensitivity syndromes in an outpatient chronic pain sample. J Pain 2013; 14: 438–445. DOI: https://doi.org/10.1016/j.jpain.2012.11.012

Johnston KJA, Signer R, Huckins LM. Chronic overlapping pain conditions and nociplastic pain. HGG Adv 2025; 6: 100381. DOI: https://doi.org/10.1016/j.xhgg.2024.100381

Yunus MB. Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes. Semin Arthritis Rheum 2007; 36: 339–356. DOI: https://doi.org/10.1016/j.semarthrit.2006.12.009

Mayer TG, Neblett R, Cohen H, Howard KJ, Choi YH, Williams MJ, et al. The development and psychometric validation of the central sensitization inventory. Pain Pract 2012; 12: 276–285. DOI: https://doi.org/10.1111/j.1533-2500.2011.00493.x

Cuesta-Vargas AI, Neblett R, Chiarotto A, Kregel J, Nijs J, van Wilgen CP, et al. Dimensionality and reliability of the central sensitization inventory in a pooled multicountry sample. J Pain 2018; 19: 317–329. DOI: https://doi.org/10.1016/j.jpain.2017.11.006

Velasco E, Flores-Cortés M, Guerra-Armas J, Flix-Díez L, Gurdiel-Álvarez F, Donado-Bermejo A, et al. Is chronic pain caused by central sensitization? A review and critical point of view. Neurosci Biobehav Rev 2024; 167: 105886. DOI: https://doi.org/10.1016/j.neubiorev.2024.105886

Clauw D, Sarzi-Puttini P, Pellegrino G, Shoenfeld Y. Is fibromyalgia an autoimmune disorder? Autoimmun Rev 2024; 23: 103424. DOI: https://doi.org/10.1016/j.autrev.2023.103424

Goebel A, Krock E, Gentry C, Israel MR, Jurczak A, Urbina CM, et al. Passive transfer of fibromyalgia symptoms from patients to mice. J Clin Invest 2021; 131: e144201. DOI: https://doi.org/10.1172/JCI144201

Katz RS, Leavitt F, Small AK, Small BJ. Intramuscular pressure is almost three times higher in fibromyalgia patients: a possible mechanism for understanding the muscle pain and tenderness. J Rheumatol 2021; 48: 598–602. DOI: https://doi.org/10.3899/jrheum.191068

Liptan GL. Fascia: a missing link in our understanding of the pathology of fibromyalgia. J Bodyw Mov Ther 2010; 14: 3–12. DOI: https://doi.org/10.1016/j.jbmt.2009.08.003